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90 The Journal of Thoracic and Cardiobjective: The Ross procedure has gained increasing interest as an attractive
lternative for aortic valve replacement. Despite its advantages, there is a certain
isk of structural valve deterioration, especially of the pulmonary homograft as a
esult of shrinkage and subsequent stenosis predominantly at the muscular annulus.
heoretically, reduction of homograft muscle tissue could reduce this risk.
ethods: From February 1996 through December 2002, a total of 238 patients
mean age 44  13.2 years) underwent the Ross procedure with the subcoronary
echnique with follow-up investigations before discharge and after 12 and 24
onths. To estimate the importance of homograft muscle reduction within our
nstitution-specific risk factor scale for change of transhomograft pressure gradient
ith time, we performed a generalized estimating equation approach, which iden-
ified homograft muscle reduction, higher body surface area in male patients,
ounger patient age, smaller homograft diameter, blood transfusions, and follow-up
ime as independent risk factors demonstrating a high  value (2.8638) for muscle
eduction. To find out whether muscle reduction influences transhomograft pressure
radient, we compared patients with (group A, n  39) and without (group B, n 
99) muscle reduction. The other mentioned independent risk factors were not
ifferent between groups, except for blood transfusions (group A greater than B,
 .01), indicating a negative bias for group A.
esults: The maximum pressure gradient across the homograft was lower in patients
ith muscle reduction before discharge (4.5 2.8 mm Hg group A vs 6.2 3.8 mm
g group B, P  .004) and after 1 (9.3  5.8 vs 13.1  8.4 mm Hg, P  .028) and
years (10.8  7.6 vs 13.7  7.5 mm Hg, P  .013). No significant differences
ere found concerning homograft insufficiency.
onclusions: We provide some evidence that transhomograft pressure gradient can
e reduced significantly within the first 2 years after operation by homograft muscle
eduction. Longer term follow-up is necessary to evaluate this promising operative
echnique further.
 
he pulmonary autograft was inaugurated by Donald Ross1 in 1967. With its
advantages of viability, immunologic identity, comparability with the native
aortic valve regarding morphology and hemodynamics, antithrombogenicity,
nd noiselessness, the pulmonary autograft is gaining growing interest after several
ublications demonstrating promising midterm results.2-7 Concerning the pulmo-
ary autograft implanted in the subcoronary technique, the pressure gradient has
hown to be excellent, simulating almost normal conditions at rest and exercise.7,8
everal patients, however, have some kind of pressure gradient develop across the
ulmonary homograft in the right ventricular outflow tract. This occurs predomi-
antly during the first 2 years after implantation, indicating a tissue reaction yet not
ompletely understood7,9 that results in shrinkage of the homograft (Figure 1). To
ate, homograft stenosis has not been shown to be related to surgical factors. We
vascular Surgery ● January 2007
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A
CDbserved that shrinkage of the homograft was pronounced
n the proximal annulus area, suggesting that implantation
f a homograft after reduction of the adjacent allogenous
uscle and replacement with a strip of autologous pericar-
ium might reduce shrinkage of the annular area and thus
he transhomograft pressure gradient. To further clarify clinical
mpact, we performed an echocardiographic follow-up inves-
igation in patients with reduction of homograft muscle and
eplacement with autologous pericardium relative to patients
ithout homograft muscle reduction.
atients and Methods
atient Population
rom February 1996 to December 2002, a total of 238 patients
187 male and 51 female) with a mean age of 44  13.2 years
range 15-70 years) underwent the Ross procedure with the sub-
oronary or root inclusion technique, followed by a close follow-up
ith echocardiographic and clinical examinations (preoperative, post-
perative before discharge, and 1 and 2 postoperative years). Clinical
ollow-up was 99% (1 patient was unavailable for follow-up because
e left Germany). Institutional review board approval and informed
onsent were obtained for each patient.
perative Procedure
or all patients, extracorporeal circulation with moderate hypo-
hermia (nasopharyngeal temperature 26°C) was used. Crystalloid
ardioplegia was applied during the first 2 years of the study; cold
lood cardioplegia was used thereafter. After implantation of the
utograft with subcoronary or root inclusion technique as de-
cribed elsewhere,7,11 the pulmonary homograft, which was
rimmed distally as short as possible (close to sinotubular junc-
ion), was inserted. In group A, a strip of pericardium was gained
uring pericardiotomy and stored in glutaraldehyde solution. This
trip (width 20 mm) was sutured onto the homograft annulus after
lmost complete removal of muscle tissue and was implanted in
he right ventricular outflow tract with 5-0 Prolene (Ethicon, Inc,
omerville, NJ) continuous suture (Figure 2). In group B, standard
nsertion was performed as described elsewhere with homologous
uscle that is used for suturing.7,11 Homograft diameters were
5.0  1.7 mm in group A and 25.5  1.4 mm in group B
difference not significant). Bypass and crossclamp times were
15  28.3 and 159  23.8 minutes, respectively, in group A and
12  30.9 (difference not significant) and 171  22.9 minutes
P  .001), respectively, in group B.
chocardiographic Data Acquisition
nd Measurements
atients were examined in left lateral decubitus position. A mod-
Abbreviations and Acronyms
AI  autograft insufficiency
GEE generalized estimating equation
PI  pulmonary homograft insufficiencyfied electrocardiographic lead I was continuously recorded. Echo- a
The Journal of Thoracicardiographic measurements were determined by two independent
bservers from video and digitally recorded studies. Transthoracic
chocardiograms were performed with a 4-S (2.5-4.0 MHz) ultra-
ound transducer (SONOS 5500 system; Philips/Hewlett Packard,
ndover, Mass) before the operation and after the operation before
ischarge, followed by two annual intervals. Average values of 5
onsecutive beats were taken. Two-dimensional measurements and
oppler investigations were conducted according to the guidelines
f the American Society of Echocardiography.12 Measurements of
iameters were taken in standard longitudinal and cross-sectional
iews. Maximum velocities at homograft level were measured
ith a continuous-wave Doppler imaging transducer. To assess
ulmonary regurgitation, pulsed and continuous-wave Doppler
nd color flow Doppler imaging were used. In the short-axis view,
emiquantitative assessment of pulmonary homograft insufficiency
PI, grade 0 to 3) was based on the length and width of the
egurgitant jet and its extension into the right ventricular outflow
ract. Peak systolic pressure gradient was calculated according to
he modified Bernoulli equation, P  4  v2 [m/s]), where P is
he gradient in millimeters of mercury and v is the peak systolic
elocity in meters per second.
etermination of Risk Factors for Homograft Stenosis
isk factors were investigated by generalized estimating equation
GEE) method as described in a later section.
omparison of Patients With and Without
eplacement of Homograft Muscle
atients with muscle reduction (group A, n  39, 31 male and 8
emale) were compared with patients without muscle reduction
group B, n  199, 156 male and 43 female). Demographic details
igure 1. Computed tomogram of conventional implanted ho-
ograft in right ventricular outflow tract.re depicted in Table 1.
and Cardiovascular Surgery ● Volume 133, Number 1 191
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A
CDtatistical Analysis
ategorical data are given as total numbers and relative frequen-
ies. Continuous data are given as mean  SD. Comparisons
etween groups were made with the Mann–Whitney U test.
omparisons of time-related data were made with the
ilcoxon signed rank test. Insufficiency grades were compared
ith the exact McNemar test. Statistical analyses were performed
ith SAS statistical software (version 8.2; SAS Institute, Inc,
igure 2. A, Exclusion of homograft muscle tissue. B, Replace-
ent of homograft muscle tissue with autologous pericardial
trip. C, Implanted autologous pericardial strip replacing muscle
issue of homograft.ary, NC). b
92 The Journal of Thoracic and Cardiovascular Surgery ● Janunalysis of GEE Parameter Estimates
EEs are proposed to analyze longitudinal data with repeated
easurements adjusting for possible correlations within the same
atients.10 We applied the GEE model to examine the influences of
number of variables on the basis of longitudinal responses. To
elect covariables for the multivariate model, univariate analyses
ere conducted with the following 27 variables possibly affecting
ranshomograft pressure gradient: sex, weight, height, body sur-
ace area, age, preoperative New York Heart Association class,
icotine abuse, hypertension, hyperlipidemia, diabetes mellitus,
nderlying valve disease (insufficiency, stenosis, combined dis-
ase), valve morphology (tricuspid, bicuspid), history of endocar-
itis, replacement of homograft muscle tissue with pericardial
trip, homograft diameter, homograft length, homograft bank ori-
in, use of a decellularized homograft (SynerGraft; CryoLife Inc,
ennesaw, Ga), transfusion (erythrocyte concentrates, fresh-frozen
lasma, or platelets), pulmonary hypertension, homograft donor age,
ypass and crossclamp times, and length of follow-up. The events per
ariable were 9. For the GEE model, we used the identity link
unction combined with a first-order autoregressive structure as work-
ng correlation.
esults
isk Factors for Homograft Stenosis
he institution-specific risk factor scale for homograft ste-
osis identified homograft muscle tissue (P  .01), higher
ody surface area in male patients (P  .01), younger
atient age (P  .01), smaller homograft diameter (P 
01), blood transfusions (P  .018), and follow-up time
P  .01) as independent risk factors with a high value for
he  parameter of the variable homograft muscle replace-
ent (2.8638).
omparison of Patients With and Without Homograft
uscle Replacement
he result of multivariate analysis confirming the influence
f homograft muscle replacement on the transhomograft
ressure gradient made us compare the patients in group A
ith those in group B to obtain exact pressure gradients (in
illimeters of mercury). All other independent risk factors
entioned were not different between groups, except for
ABLE 1. Demographic data
With
pericardial
strip
Without
pericardial
strip
o. 39 199
ex (male/female) 31:8 156:43
ge (y, mean SD) 46.0 15.1 44.1  12.9
eight (cm, mean SD) 173 9.4 175  9.1
eight (kg, mean SD) 78 13.9 77  15.0
ody surface area (m2, mean  SD) 1.9  0.2 1.9  0.2
ollow-up (mo, mean SD) 22.6 3.9 22.7  4.2
here were no significant differences between groups.lood transfusions (group A more than group B, P  .01).
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A
CDortality
arly mortalities were 1 in group A and 1 in group B. Late
ortality was 2 in group A. No deaths were valve related.
eoperation of the Homograft
n group A, 1 patient (2.6%) had to undergo reoperation on
he homograft because of combined pulmonary valve dis-
ase with dominant stenosis 13 months after the Ross pro-
edure. In group B, 3 patients (1.5%) underwent reopera-
ion, 2 for PI (14 and 15 months after the initial operation)
nd 1 for stenosis (16 months after the initial operation).
omograft Function
he postoperative gradients before discharge showed lower
alues in group A. One year after the Ross procedure, a
ignificant increase of pressure gradients could be observed
n both groups, with higher gradients in group B. During the
rst postoperative year, there was a further significant in-
rease in group B but not in group A. The maximum
ressure gradient 2 years after the Ross procedure was
ignificantly higher in group B (P  .0132). Values are
epicted in Table 2.
PIs were comparable after the operation before discharge
P  .7062), as well as during the first (P  .7904) and
econd years of follow-up examination (P  .2613). In
roup A, there was no significant difference in PI grade in
ither the postoperative echocardiography before discharge
grade 0 PI 89.3%, grade 1 PI 10.7%, grade 2/3 PI 0%)
elative to the first year follow-up examination (grade 0 PI
8.9%, grade 1 PI 21.1%, grade 2/3 PI 0%, P  .6547) or
ABLE 2. Homograft pressure gradients
PO
roup A, with pericardial strip
Maximum pressure gradient (mm Hg)
Mean SD 4.5 2.8
Range 1.8-12.6
Mean pressure gradient (mm Hg)
Mean SD 2.5 1.5
Range 1.0-7.4
roup B, without pericardial strip
Maximum pressure gradient (mm Hg)
Mean SD 6.2 3.8
Range 1.5-32
Mean pressure gradient (mm Hg)
Mean SD 3.2 1.4
Range 1.0-8.0
values
Maximum gradient (mm Hg) .0042*
Mean gradient (mm Hg) .0056*
O, Postoperative examination before discharge. *Significant difference.he first year relative to the second year follow-up investi- t
The Journal of Thoracication (grade 0 PI 63.9%, grade 1 PI 33.3%, grade 2 PI
.8%, grade 3 PI 0%, P  .5637). In group B a significant
ncrease was documented during the first postoperative year
postoperative examination before discharge/first year grade
PI 92.3%/80.6%, grade 1 PI 7.7%/18.7%, grade 2 PI
%/0%, grade 3 PI 0%/0.7%, P  .0094) without further
hange during the following year (grade 0 PI 76%, grade 1
I 22.4%, grade 2 PI 1.6%, grade 3 PI 0%, P  .4545).
utograft Function
he autograft showed near physiologic maximum pressure
radients for both groups (group A postoperatively before
ischarge 10.5 5.1 mm Hg, year 1 6.5 2.8 mm Hg, year
5.9  2.2 mm Hg; group B postoperatively before dis-
harge 8.9  5.1 mm Hg, year 1 6.3  3.4 mm Hg, year 2
.9  3.1 mm Hg) without significant differences between
roups. Concerning autograft insufficiency (AI), there were
lso no differences between groups (group A postoperatively
efore discharge/first year/second year AI grade 1 or better
00%/100%/100%; group B postoperatively before discharge/
rst year/second year AI grade 1 or better 100%/97.9%/96.9%,
rade 2 AI 0%/1.4%/3.1%, grade 3 AI 0%/0.7%/0%).
iscussion
ulmonary autograft replacement of the diseased aortic
alve has several advantages, such as excellent hemodynam-
cs, durability, potential to grow, viability, immunologic iden-
ity, antithrombogenicity, and noiselessness. Especially note-
orthy, the survival after the Ross procedure is higher than
Follow-up P value
1 y 2 y PO-1 y 1-2 y
.0034* .4747
9.3  5.8 10.8 7.6
3.1-21.5 1.9-37.2
.0020* .3776
5.4 3.3 6.2  4.4
1.8-12.3 1.1-21.5
.001* .001*
3.1 8.4 13.7 7.5
1.7-49.8 1.6-43.3
.001* .001*
7.1  4.8 7.6  4.9
1.0-28.4 1.2-35.0
.0282* .0132*
.1068 .06641hose with other valve substitutes.13,14 The insertion of a
and Cardiovascular Surgery ● Volume 133, Number 1 193
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1
A
CDalved conduit in the right ventricular outflow tract (preferably
ulmonary homograft) is necessary in the Ross procedure.
here is concern about the development of pulmonary ho-
ograft dysfunction, especially homograft stenosis. Several
ublications have described the problems of shrinkage and
alve degeneration.15-18 A number of risk factors for failure or
tenosis of the homograft in the right ventricular outflow
ract—predominantly occurring during the first 12 to 24 post-
perative months—have been evaluated, including small ho-
ograft diameter, young recipient age, younger donor age,
ortic homografts, shorter duration of cryopreservation, and
onger aortic crossclamp time.19-22 In our institutional analysis,
he independent factors influencing homograft pressure gradi-
nt during the first 2 years after operation were homograft
uscle reduction, higher body surface area in male patients,
ounger patient age, smaller homograft diameter, blood trans-
usions, and follow-up time. Patients with and without reduc-
ion of muscle tissue were comparable with respect to sex, age,
ollow-up time, and homograft diameter. Moreover, patients
ith muscle reduction had lower pressure gradients even
hough they received a greater number of blood transfusions,
hich was a predictive factor for development of homograft
tenosis.
Other investigators have not found any predictive factors
or homograft dysfunction or reoperation but have found a
ronounced adventitial reaction producing extrinsic com-
ression, associated with histologic features suggestive of
nflammatory-mediated fibrotic reaction.23 To date, surgery
as not been reported on as a predictive factor.
Because most stenoses occur during the first 2 postoper-
tive years, with stable pressure gradients thereafter, we
erformed echocardiographic examinations postoperatively
efore discharge and after 1 and 2 years.23,24 Also after 5
ostoperative years, we found the same results, with signif-
cantly lower gradients in group A (maximum/mean tran-
homograft pressure gradients in group A 11.1  5.5/5.6 
.5 mm Hg and in group B 16.4  9.9/8.6  5.8 mm Hg,
 .0168/.0118). Only pulmonary homografts were im-
lanted. The location of pulmonary homograft stenosis has
een described to occur in the tubular part of the homograft
n the distal suture lines, rarely in the valves themselves,23
ut predominantly at the annular area. These findings were
n accordance with our own unpublished computed tomo-
raphic results of echocardiographically proven homograft
tenosis. This was the rationale for the applied surgical tech-
ique, the excision of homograft muscle tissue with subsequent
eplacement with autologous pericardium (Figure 3). We in-
estigated this operative technique with multivariate GEE
nalysis and found that the reduction of muscle tissue of the
onor pulmonary homograft had a high influence on the pro-
ression of the transhomograft pressure gradient ( of 2.8).
ecause of this finding, we compared two groups of patients:
roup A, patients with reduction of muscle tissue and its g
94 The Journal of Thoracic and Cardiovascular Surgery ● Januubsequent replacement with autologous pericardium, and
roup B, patients without such reduction. Patients with re-
lacement of muscle tissue (group A) already had lower max-
mum pressure gradients across the homograft postoperatively
efore discharge, as well as at 1 and 2 years. No differences
ere found between groups concerning the grade of PI. These
esults provide evidence that the operative strategy of extin-
uishing as much extrinsic tissue as possible can help to avoid
ncreasing transhomograft pressure gradients during the first
years.
In group A, autologous pericardium preserved with glu-
araldehyde was used to replace the resected subvalvular
uscle tissue to provide adequate material for homograft
mplantation. This material may undergo shrinkage or dila-
ation, however, and thus become unpredictable with re-
pect to long-term results. We therefore recently replaced
uscle tissue with Gore-Tex (W. L. Gore & Associates, Inc,
lagstaff, Ariz) instead of pericardium because it has a
ower risk of changing dimension with time. It is most
mportant to follow the scalloped arrangement of the annuli
f the homograft valve to warrant almost complete resection
f muscle tissue.
This study has some limitations. It is a retrospective
nalysis rather than a prospective, randomized trial. Never-
heless, the demographic data and those factors having an
nfluence on pressure gradient, except for blood transfusion,
ere comparable between the groups. The group with mus-
le resection had more blood transfusions, indicating a
egative bias. Although this group showed lower pressure
igure 3. Computed tomogram of homograft in right ventricular
utflow tract with implanted autologous pericardial strip.radients (strengthening the value of the muscle resection)
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A
CDxaminations of panel reactive antibody assays or inflam-
atory indicators would be desirable to analyze any im-
une or inflammatory responses.
In conclusion, almost complete muscle resection of ho-
ograft seems to provide promising results. Long-term
tudies are necessary to evaluate this encouraging operative
echnique further.
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